Else Nutrition Holdings Inc (BABY) News

Good suggestion but there is multiple ways to market our product. This being said, i believe that our CEO left her previous employment, frustrated to see the company invest in marketing instead of product development. She then decided to create this company aimed at developping products that she not only doesn't understand how to market them but is totally reluctant to SPEND any money trying to do any kind of marketing (She believe that INVESTING in marketing is a useless EXPENSE.
She will prefer to fail (she is off a good start) instead of admitting she is totally ridiculous putting inventories on shelves, expecting that it will sell by itself.
If she had good partners around her (such as BOD members) she maybe could be educated somewhat but she created a board made of scientific people most likely not qualified to help her understand ... unless she is even more stubborn than i tought ???

and the best and cheapest way to do that is one is online marketing! brick and mortar is not the path to follow - only one that would have made sense besides Walmart is Costco

Putting products no one knows about on shelves is close to spreading an inventory all over the place.
THE THING TO DO: Tell the people what we are all about and how our offer can benefit to them is MANDATORY. Our scientific CEO doesn't understand that and is so stubborn that she still believe after 5 years that people do buy product they do not know about.
WHAT WILL IT TAKE FOR HER TO FIGURE OUT SHE IS GONNA FAIL IF SHE KEEPS ACTING STUPID?

It was on the shelves but don’t know about now. This was when stock was around 2-3 dollars a share.

A decent bid shows up:
Bid x Size
$0.043 x 339,555
Ask x Size
$0.045 x 50,000
Real Time Equity Quote: Aug 29, 2024, 12:20 PM ETinfo_outline

LV, I dk if we are on shelves or just @ Walmart
on line. I seem to recall on line was mentioned.
I'll drop in for a quick check & see.

LV, I dk if we are on shelves or just @ Walmart
on line. I seem to recall on line was mentioned.
I'll drop i for a quick check & see.

Amazing how this went to all the Walmart shelves and now .4 pennies a share.
Junk penny stock now

I DK if the corp owns the patents or the individuals do.
Eventually if the Co goes belly up, the patents have value.

Not a bad idea (I did at CDN 0,065 recently). However till she decides to get help or sell out her company, we will not lose much but all we chipped in.
That story reminds me (among other stories), whe the Japaneeses did create the BETAMAX video technology being 20 times better than the then very popular VHS one. NOT UNDERSTANDING THE MARKET THEY WERE GETTING INTO, they ended up abandonning their project after failing to generate serious revenues. I also know about another Japaneese company developping a computer multiple times better than the then IBM product covering the whole market. Again, NOT UNDERSTANDING THE MARKET THEY WERE TRYING TO CONQUER, they endedup having to abandon the project.
In both cases the japaneese companies were made of much superior ENGINNEERS not understanding what the market they were getting in was all about.
Both companies failed miserably notwithstanding their much better offering.
The way our ''product engeneer type'' CEO behaves we may very well become the next example of a company failing notwithstang their much bette offering.

Bought a few also this a.m.

One more PRODUCT-ORIENTED message, one more product no one knows anything about and this sent to shareholders most likely not even users of this product.
Our CEO firmly believe notwithstanding her experience (Shares at $3,19 in August 2021, $1,40 in march 2022 and $0,06 today) that developping and throwing products on shelves will make the company successful.
She obviously remains to be a dreamer not understanding the business she think she is trying to build. Most likely a freat scientific researcher but as a business manager she keeps showing she doesn't understand whatsoever what her job must be as a CEO.
What a pitty!

buying a few in the .04's

(PR) Else Nutrition Announces Launch of Plant-Powered, Ready-to-Drink Kids Shakes at a Southern California's Premier Upscale Grocery Chain
7:30 AM ET 8/29/24 | PR Newswire

Else Nutrition Announces Launch of Plant-Powered, Ready-to-Drink Kids Shakes at a Southern California's Premier Upscale Grocery Chain

PR Newswire

VANCOUVER, BC, Aug. 29, 2024

VANCOUVER, BC, Aug. 29, 2024 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), is pleased to announce the launch of its plant-powered, Ready-to-Drink Kids Shakes, available in Chocolate and Vanilla flavors, at a Southern California's leading upscale grocery store chain. Beginning in September, Else Nutrition's nutritious kids shake will be available in 19 locations across the region, accompanied by promotional offers.

"We are delighted to collaborate with this esteemed grocery chain to increase the accessibility of our delicious Kids Ready-to-Drink products for families in Southern California," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This partnership is a natural fit for Else Nutrition, as we both prioritize offering high-quality, healthy, and flavorful food options to our customers."

The grocery chain, with 19 stores strategically located from Santa Barbara to Los Angeles to Palm Springs, has earned a distinguished reputation for delivering the best-tasting food and the freshest ingredients. Known for its unique blend of quality, value, and an exceptional shopping experience, the chain has become a leader in the grocery industry, renowned for its freshness, homemade quality, and the inviting atmosphere that welcomes every shopper.

Else Nutrition's new Kids Shakes are perfectly aligned with the core values of the California grocery chain, particularly its dedication to culinary innovation and providing customers with the finest food choices. Crafted from the cleanest, whole-food ingredients, Else Nutrition's products are plant-Based, dairy-free, soy-free, and free from added sugars, offering a balanced nutritional profile that parents can trust.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to early childhood nutrition, visit www.elsenutrition.com

(PR) Else Nutrition Announces Launch of Plant-Powered, Ready-to-Drink Kids Shakes at a Southern California's Premier Upscale Grocery Chain
7:30 AM ET 8/29/24 | PR Newswire

Else Nutrition Announces Launch of Plant-Powered, Ready-to-Drink Kids Shakes at a Southern California's Premier Upscale Grocery Chain

PR Newswire

VANCOUVER, BC, Aug. 29, 2024

VANCOUVER, BC, Aug. 29, 2024 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), is pleased to announce the launch of its plant-powered, Ready-to-Drink Kids Shakes, available in Chocolate and Vanilla flavors, at a Southern California's leading upscale grocery store chain. Beginning in September, Else Nutrition's nutritious kids shake will be available in 19 locations across the region, accompanied by promotional offers.

"We are delighted to collaborate with this esteemed grocery chain to increase the accessibility of our delicious Kids Ready-to-Drink products for families in Southern California," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This partnership is a natural fit for Else Nutrition, as we both prioritize offering high-quality, healthy, and flavorful food options to our customers."

The grocery chain, with 19 stores strategically located from Santa Barbara to Los Angeles to Palm Springs, has earned a distinguished reputation for delivering the best-tasting food and the freshest ingredients. Known for its unique blend of quality, value, and an exceptional shopping experience, the chain has become a leader in the grocery industry, renowned for its freshness, homemade quality, and the inviting atmosphere that welcomes every shopper.

Else Nutrition's new Kids Shakes are perfectly aligned with the core values of the California grocery chain, particularly its dedication to culinary innovation and providing customers with the finest food choices. Crafted from the cleanest, whole-food ingredients, Else Nutrition's products are plant-Based, dairy-free, soy-free, and free from added sugars, offering a balanced nutritional profile that parents can trust.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to early childhood nutrition, visit www.elsenutrition.com

''I really feel for you dude'' ... As I said earlier I initially bought in since 2019-12-10 (buying at CDN S0,380) and traded a lot till April 12, 2021 when I sold 3/4 of my shares at $3 + for my birthday gift. Thereafter, I bought back most of my shares in Januaryper 20 22 then thingking that at $1,25 we must have reached a bottom (Oups!) ... My average net cost then become more or less $0,35 cents. I doubled my ownership yesterday at $0,065 to reduce that cost below $0,20).

I think that your hypothesis is a potential outcome (''CEO has to step down, either they try to go this on their own with a new CEO or cut a deal with the mega company''), assuming our CEO is not totally stupid. After all she also have investment to lose.

Worst case the woman is stupid enough to go bancrupt, best case she goes as per your hypothesis. Worst case I lose money I can afford to lose with minimal payne, best case I net a nice profit. After all the product line is great, the patents are worth a lot and some mega companies are not that well equipped product-wise nowadays.

I really feel for you dude. I haven't checked into the stock in the longest time. I cashed out a long time ago with a mega profit. Once it broke to the upside into the $3 range I started scaling out. I did take some positions when it fell back to 20 cents and then it had to run up to 50 cents and sold those.
My take on this. CEO has to step down, either they try to go this on their own with a new CEO or cut a deal with the mega company and just become another company under the umbrella. They are not too many shares out there and this is ripe for a company to take over or even someone with big bucks to Simply buy the darn thing. CFO blew it big time because when I went to $3 they should have done everything they could to keep it there and get themselves off the over-the-counter. Pretty much the only ones that can own this at this point or retailers and that's not going to cut it. I have not been following enough to know if they've been able to stay afloat by themselves or someone's backing them. From 1 to 10 the product is an 11. CEO is running into the ground. I'm tempted to buy again but I don't know who's going to be a buyer on the other side is going to bid it up. Hang in there you got my prayers.

I also bought a few @.051

This being said, at $0,065 I decided to average down somewhat, thinking that maybe our CEO will endup waking up to figure out what is wrong with her refusal to get help ??? Who knows ???

Here is a summary of our situation:
- Does not have a meaningful market cap (CA$10M)
- Has less than 1 year of cash runway
- Earnings have declined by 7.4% per year over past 5 years
- Shareholders have been diluted in the past year
- Volatile share price over the past 3 months Share Price

What does our CEO do about that?
- Dilute us even more to finance the operations,
- Does nothing to grow revenues (Adding shelves only increases costs - inventories)
- Reduces expenses (instead in investing in marketing)

She is a competent scientific person enjoying a board of people like her
She has no respect for any marketing programs looking at it as ''expenses'' instead of investment,
She believes great products suffice to be successful

Bottom line: SHE IS AN INCOMPETENT BUSINESS EXECUTIVE

beginning to think pps has hit bottom. if so, only one way to go: up

bought a small # of shares today. seems cheap enough at this level.

$ 12,000,000 market cap or so. What a bad joke. Unfortunately our CEO controls the company and would keep running after her dream instead of doing anything to succeed somewhat.
We have the product, the patents, the distribution network and still, we cannot generate any significant profitable revenue.
It would not required that a genius to rapidly figure out what is wrong and the answer has nothing to do with cutting expenses. How in the world can't our CEO figure that out ?

Honestly at that pps I would buy tens of thousands shares wasn't it that the incompetent stubborn CEO wasn't that crazy.

Another 10% down today. The woman is prepare to lose it all instead of letting someone manage the company with competence. She dream of a miracle (FDA) that will be meaningless considering the market does'nt know what our offer is ... even currently. How stupid can someone be ???

Nobody wants to board ship, but many jumpers off:
$0.0625-0.0071 (-10.20%)
Bid x Size
$0.0613 x 21,000
Ask x Size
$0.0629 x 100,000
Real Time Equity Quote: Aug 16, 2024, 2:44 PM ETinfo_outline

18% down today ??? What will it take for our CEO to figure out she (we) need help from someone able to manage the company as a commercial business instead of a lab center?

Cutting EXPENSES is nice but not INVESTING in marketing to inform potential markets is a shortcoming that will keep limiting the growth of our business. Fact is we could have an extremely larger revenue\profit result if only our CEO accepted to tell the market about our offerings, instead of just covering the shareholders.

I have a joyfull retirement but also want to keep documenting the shortcomings and irresponsibility of our CEO. Till proven wrong, I shall keep factually report what is obviously the stubborness of our CEO.

Has a corner been turned?
Gross profit in Q2 2024 increased to $263 thousand, or 10% of revenue,
compared to a gross loss of $50 thousand or (-2%) of revenue in Q2 2023.

Press Release: Else Nutrition Reports 2024 Second Quarter Financial Results and Provides Business Update
7:00 AM ET 8/14/24 | Dow Jones

Else Nutrition Reports 2024 Second Quarter Financial Results and Provides Business Update

Canada NewsWire

VANCOUVER, BC, Aug. 14, 2024

Q2 2024 revenue increased 23% to $2.6 million over Q1 2024

Q2 2024 retail sales increased 88% and 111% over Q1 2024 in the U.S. and Canada, respectively

Conference call to be held today at 10:00 AM Eastern Time

VANCOUVER, BC, Aug. 14, 2024 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today reported financial results for the second quarter ended June 30, 2024. The financial statements and MD&A are available on SEDAR under the Company's profile.

"We are rapidly expanding our market presence," commented, Hamutal Yitzhak, CEO of Else Nutrition. "Most notably, our toddler and kids products continue to gain traction as we add major retailers across North America. Specifically, we added several key accounts in the last few months, including Wegmans, HEB, Meijer, and 600 new Walmart U.S. stores, started selling our new Kids RTD line at Loblaws, Giant and Metro, and added Walmart's Canadian website, Walmart.ca. As a result, our revenue increased 23% to $2.6 million in the second quarter of 2024 and we achieved 88% and 111% sequential retail sales growth in the U.S. and Canada, respectively. We believe these results are a strong validation of the market demand for nutritious and healthy alternatives."

"We are also gaining traction in the market with our kids ready-to-drink (RTD) products, demonstrating its broad appeal. Since the launch, we have observed a rapid increase in sales, reflecting strong consumer demand and positive reception. The positive reviews and testimonials further attest to its quality and taste, enhancing our brand's reputation. In fact, our RTD products earned the prestigious Mom's Choice Award. The impressive market performance we are witnessing positions us for future growth and expansion."

"In addition, we recently announced that the Navy Exchange Service Command, or NEXCOM, has listed our full product line. The Navy Exchange offers a variety of goods and services to active military personnel, retirees, and certain civilians on Navy installations in the United States, overseas Navy bases, and aboard Navy ships. We are pleased to report that we have delivered the first shipment of our full range of products to NEXCOM's retail stores. We believe this agreement will serve as a foothold into broader military channels, providing those who serve and their families access to high-quality, nutritious options."

"Furthermore, during the first half of 2024, we moved our U.S. powder production to a new plant, cutting production cost by almost half, and moved to a new packaging partner that reduced our packaging costs and improved our product shelf-life. Over the next several months we plan to add another powder production and packaging facility in Europe that will offer additional cost savings and quality improvements. "

"Overall, we are committed to growing our revenue and capturing a significant share of this multi-billion market, while progressing towards profitability and driving value for our shareholders," concluded Ms. Yitzhak.

2024 Second Quarter Financial Results

All figures are in CAD unless otherwise indicated.
-- Revenue for Q2 2024 increased approximately 10% to $2.60 million compared
to $2.37 million for the same period last year. Revenue for Q2 2024
increased 23% sequentially to $2.6 million compared to Q1 2024.

-- Operating expenses for Q2 2024 decreased 19% to $3.4 million compared to
$4.2 million in Q2 2023.

-- Gross profit in Q2 2024 increased to $263 thousand, or 10% of revenue,
compared to a gross loss of $50 thousand or (-2%) of revenue in Q2 2023.

-- Cash balance as of June 30, 2024, was $1.4 million (including restricted
cash). Subsequent to the quarter, the Company raised US$2 million.

Conference Call

Else Nutrition management plans to host a business update conference call at 10:00 a.m. Eastern Time today to discuss the Company's financial results for the 2024 second quarter ended June 30, 2024, as well as the Company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1682281&tp_key=2832279e6a or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.

A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through August 14, 2025. A telephone replay of the call will be available approximately three hours following the call, through August 21, 2024, and can be accessed by dialing 1-844-512-2921 for U.S. callers or +1-412-317-6671 for international callers and entering conference ID: 13748206.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit

-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category

-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo

-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category

-- During September 2022, Else Super Cereal reached the #1 Best Seller in
Baby Cereal across all brands on Amazon

-- In May 2024 Else Nutrition's Ready-to-Drink Kids Vanilla Shake Named
Among the Best in Family-Friendly Products by the Prestigious Mom's
Choice Awards(R)

TSX

Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-reports-2024-second-quarter-financial-results-and-provides-business-update-302221842.html

SOURCE Else Nutrition Holdings Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/August2024/14/c6375.html

/CONTACT:

Investor Relations Contact: Alexandra Schilt, Crescendo Communications, LLC, Office: (212) 671-1020, Email: baby@crescendo-ir.com
Copyright CNW Group 2024


> Dow Jones Newswires

August 14, 2024 07:00 ET (11:00 GMT)

The only change since my last visit here years ago is pual's derangement and subsequent increase in negative energy. There must be better ways to enjoy retirement.

Stupid but you may be right. Our CEO is so incompetent that nothing would surprise me anymore.

This looks like dilution and a R/S coming imo

The fake food fad ended/crashed three years ago.

CSF (Critical success factors) – Posted in November 2021
Sometimes, a superior product disappears from the market. This was the case with Betamax expecting to replace VHS. Despite being technologically superior to VHS, Betamax lost market share until it eventually vanished. Companies that don’t implement effective marketing strategies and techniques that actually benefit their good products will find themselves among the list of marketing failures examples.
An R & D team works to create and define new products and features. The marketing team on the other hand focuses on bringing those products to market.
A marketing team should be qualified to define an overall vision and strategy. This team should then be responsible for defining, building, communicating and executing a product's go-to-market strategy.
The core skills and qualities required within each team are very different. These skills and qualities must be considered before determining which role is right for who within the organisation. I really hope our CEO will understand that soon.
Unfortunately the type of persons focussing on the R & D type of activities to often believe that : ‘If a product is good, it will sell’.
Let’s hope our CEO rapidly figures out that this belief is leading to failure.

I just find the notes I took out of the conference call held 2,5 years ago.BABY. The stock then was trading at more or less CDN 1,75

Conference18-11-2021 (some abstracts)
*2021 "was a year of laying the foundation for growth"
*Going to be in 7 largest markets on Amazon EU in Q1 2022
*"Very profitable in next 2-3 years"

And the most ridiculous ones:
*expanding scientific advisory board, even more
*"Empire's take time to build" - CEO

I wonder what the next conference will give as excuses for the ongoing faillure ???

Somebody is willing to buy some:
Bid x Size
$0.0861 x 264,239
Ask x Size
$0.09 x 30,000
Real Time Equity Quote: Aug 8, 2024, 2:27 PM ETinfo_outline

Once again, we will listen to the excuses and promisses of our CEO.
This company has become the toy of scientifics thinking success can only come from our products but having no clue what operating a marketing project is all about. These incompetent ''Business managers'' have no clue relative to what is needed marketing wise to generate sales and revenues. By the way, any qualified marketeer executive would know that advertizing (assuming they do any serious one) is only a component of what a real MARKETING STRATEGY is all about.
They dream of the day FDAs approval will come (if ever) but that will leed to nothing different, unless they do whatever is needed to provoque sales at appropriate profitable pricing. Once more they will inform the shareholders of the good news (if good news are coming) and save costs of doing appropriate INVESTMENTS in marketing, costs they consider an unnecessary EXPENSE.
Many companies with much less of an opportunity with an offering created huge commercial success. Many other ones with great innovative offerings failed because management was incompetent. Some of the later were fortunate enough to sellout their companies at discounted price before going bancrupt just to see their buyers make huge success out of the products they did acquire.

FDA, Danone. Lie after lie. After the earnings report this goes to sub penny by end of year. Four years holding this crap, money and time lost. Wish we (I mean actual investors) could come together and make these bastards repay the money they stole from us. Are we really in Meijer, or Wegmans or HEB? Does anybody on this board live in these areas and can verify these products are in these places?

(PR) Else Nutrition Schedules Second Quarter 2024 Business Update Conference Call
9:00 AM ET 8/6/24 | PR Newswire

Else Nutrition Schedules Second Quarter 2024 Business Update Conference Call

PR Newswire

VANCOUVER, BC, Aug. 6, 2024

VANCOUVER, BC, Aug. 6, 2024 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at 10:00 a.m. Eastern Time on August 14, 2024 to discuss the Company's financial results for the 2024 second quarter ended June 30, 2024, as well as the Company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1682281&tp_key=2832279e6a or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.

A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through August 14, 2025. A telephone replay of the call will be available approximately three hours following the call, through August 21, 2024, and can be accessed by dialing 1-844-512-2921 for U.S. callers or +1-412-317-6671 for international callers and entering conference ID: 13748206.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com.

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit

-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category

-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo

-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category

-- During September 2022, Else Super Cereal reached the #1 Best Seller in
Baby Cereal across all brands on Amazon

TSX

Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID-19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/else-nutrition-schedules-second-quarter-2024-business-update-conference-call-302215239.html

SOURCE Else Nutrition Holdings Inc.

/CONTACT: Investor Relations Contact: Alexandra Schilt, Crescendo Communications, LLC, Office: (212) 671-1020, Email: baby@crescendo-ir.com


> Dow Jones Newswires

August 06, 2024 09:00 ET (13:00 GMT)

Honestly, so do i ???
However if we had a serious CEO, she would have updated us. I assumme she is too busy trying to acquire new shelves to put on more inventory of products nobody knows about.

I'm beginning to think FDA approval is just a pipe dream.

That is what our CEO works on ???????

That is what our CEO works on ???????

If anyone cares:
Else Nutrition With Partnership Expansion Announcement
7:59 AM ET 7/30/24 | MT Newswires
Else Nutrition With Partnership Expansion Announcement
07:59 AM EDT, 07/30/2024 (MT Newswires) -- Else Nutrition Holdings (BABY.TO), which saw its shares jump 8.7% from near 52 week lows yesterday, on Tuesday announced its expanded partnership with Walmart, involving the launch of its entire product line on the superstore's Canadian online store in August 2024.

Canadian consumers will be able to purchase Else Nutrition's full range of products, including Toddler Nutrition, Kids Shakes, Ready-To-Drink (RTD) nutrition shakes and cereals, directly through the online platform of the retailer, which has 403 stores nationwide.

The retailer's Canadian division serves 1.5 million customers each day and hosts more than 1.5 million daily visits to the Canadian e-store.

https://www.yahoo.com/news/abbott-laboratories-must-pay-495-024900377.html

Traded this stock initially
2019-12-13 BUY 1800 $0,380
2019-12-19 BUY 2950 $0,400
2020-01-06 SELL -3500 $0,475
At the time our drweaming CEO was forecasting a $5 per share within 5 years

I thereafter kept trading up to 3 years ago accumulating
2021-01-20 BUY 2900 $3,55
2021-02-12 Sell -2900 $4,100 my last trading activity

I am still baddly under water my net cost being $1,23 following this last trading activity

That would not surprise it at all since our CEO is obviously stupid.

A couple years ago, this stock used to be over Dollar.